List view / Grid view
13 May 2016 | By Victoria White, Digital Content Producer
Scientists also found that inhibiting oestrogen synthesis just after seizure onset strongly suppressed seizures in both sexes...
12 May 2016 | By Victoria White, Digital Content Producer
Dr Andrei Goga of UC San Francisco has taken a multi-faceted approach to identifying new therapeutic targets in MYC-driven triple-negative breast cancers...
11 May 2016 | By Victoria White, Digital Content Producer
Pfizer has awarded a total of more than $1 million in funding to five leading advocacy organisations to support metastatic breast cancer scientific research...
10 May 2016 | By Victoria White, Digital Content Producer
Scientists have designed a drug candidate, Targaprimir-96, that decreases the growth of tumour cells in animal models of triple negative breast cancer...
3 May 2016 | By Victoria White, Digital Content Producer
Scientists have shown how small structural changes in a key breast cancer receptor can produce predictable effects in curbing or accelerating cancer growth...
20 April 2016 | By Victoria White, Digital Content Producer
Emergent BioSolutions' ES425 molecule is being developed as a potential therapeutic for triple-negative breast cancer (TNBC)...
12 April 2016 | By Victoria White, Digital Content Producer
The discovery means that a family history of DCIS could be as important to assessing a woman’s risk as a history of invasive breast cancer...
7 March 2016 | By Victoria White
Scientists have provided a deeper insight into how BRCA1 functions in normal breast tissue and how its loss results in breast cancer...
9 February 2016 | By Victoria White
The programme aims to bring together breast cancer researchers and pharmaceutical companies to pool resources and stop women dying from breast cancer by 2050...
2 February 2016 | By Victoria White
A team of scientists from Bath, Cambridge and the USA has identified a piece of non-coding RNA that stops cells turning cancerous...
19 January 2016 | By Victoria White
The largest analysis of breast cancer cell function to date suggests dozens of new uses for existing drugs, new targets for drug discovery, and new drug combinations...
8 January 2016 | By Victoria White
The first-in-class candidate, CB1, has shown potent anti-metastatic activity, and with an impressive in vivo efficacy and safety profile...
23 December 2015 | By Victoria White
A team at CSHL has announced preclinical data suggesting the promise of a novel drug directed against a novel target in malignant mammary tumours...
4 December 2015 | By Victoria White
ICR scientists have discovered Brf2 acts as a ‘master switch’ within cancer cells that seems to override the normal stress response...
2 December 2015 | By Victoria White
GBI Research states that the majority of oncology therapeutics are in the early stages of the pipeline, with 2,937 at the Preclinical stage and 1,591 at the discovery stage...
